Article Versions Notes

Hattori S, Yoshikawa N, Mogi K, Yoshida K, Yoshihara M, Tamauchi S, Ikeda Y, Yokoi A, Nishino K, Niimi K, et al. Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer. Current Oncology. 2021; 28(3):1663-1672. https://doi.org/10.3390/curroncol28030155

Hattori, Satomi, Nobuhisa Yoshikawa, Kazumasa Mogi, Kosuke Yoshida, Masato Yoshihara, Satoshi Tamauchi, Yoshiki Ikeda, Akira Yokoi, Kimihiro Nishino, Kaoru Niimi, and et al. 2021. "Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer" Current Oncology 28, no. 3: 1663-1672. https://doi.org/10.3390/curroncol28030155

Hattori, S., Yoshikawa, N., Mogi, K., Yoshida, K., Yoshihara, M., Tamauchi, S., Ikeda, Y., Yokoi, A., Nishino, K., Niimi, K., Suzuki, S., & Kajiyama, H. (2021). Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer. Current Oncology, 28(3), 1663-1672. https://doi.org/10.3390/curroncol28030155